Trials / Unknown
UnknownNCT02854930
Near Death Experience (NDE) and Migraine
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Assistance Publique Hopitaux De Marseille · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Migraine is a common disabling primary headache disorder. Epidemiological studies have documented its high prevalence and high socio-economic and personal impacts. Migraine affects more than 20% of the French population. However, the physiopathology of migraine is always partially known. Cortical spreading depression (CSD) is the widely accepted as the electrophysiologic substrate of migraine aura. CSD is a slowly propagating wave of transient neuronal and glial depolarization. The near death experience (NDE) is a rare, but well known phenomenon. NDE are profound psychic experiences commonly occuring in life-threatening conditions. Among the neurological hypotheses, epilepsy, temporal lobe disorders , REM-sleep intrusion have been discussed. However, the role of DCE has never been discussed. The goals of this study are : to see if there is an epidemiological link between NDE and migraine/ to specify if NDE was followed by a migrainous headache.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | questioning |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2018-01-01
- Completion
- 2018-03-01
- First posted
- 2016-08-04
- Last updated
- 2016-08-04
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02854930. Inclusion in this directory is not an endorsement.